Comparison between the Prognosis of Temporomandibular Disorders with and without Accompanying Otologic Symptoms after Non-Invasive Non-Pharmacological Treatment: Controlled Clinical Trial.
Samer Al Akkad, Mohammad Y Hajeer, Marwan Al Akkad
{"title":"Comparison between the Prognosis of Temporomandibular Disorders with and without Accompanying Otologic Symptoms after Non-Invasive Non-Pharmacological Treatment: Controlled Clinical Trial.","authors":"Samer Al Akkad, Mohammad Y Hajeer, Marwan Al Akkad","doi":"10.14712/18059694.2026.13","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Otologic symptoms are commonly reported by patients with temporomandibular disorders.</p><p><strong>Objective: </strong>This study aims to investigate the likely outcome or progression of temporomandibular disorders with and without accompanying otologic symptoms when treated in the dental clinic.</p><p><strong>Methods: </strong>The study is registered under the International Standard Randomised Controlled Trial Number: ISRCTN49976724, DOI: 10.1186/ISRCTN49976724. Forty patients with temporomandibular disorders were included and allocated into two groups: Control group (n=20): isolated temporomandibular disorders symptoms, and Experimental group (n=20): temporomandibular disorders symptoms with otologic symptoms (confirmed by otorhinolaryngological evaluation to exclude primary ear pathology). All participants underwent non-invasive, non-pharmacological treatment. The treatment contained physiotherapy and custom-made occlusal splints. Outcomes (full/partial/no recovery) were assessed at 3 months by a single maxillofacial surgeon, with follow-up every 3 weeks. Statistical analysis included Fisher's exact test and odds ratios.</p><p><strong>Results: </strong>Fisher's exact test revealed a statistically significant association between group allocation and recovery outcomes (χ2=5.979, p=0.041). The odds ratio was 5.33.</p><p><strong>Conclusion: </strong>The presence of otological symptoms accompanying temporomandibular disorders might predict a better prognosis after non-invasive, non-pharmacological treatment, perhaps not as a direct predictor per se but as a confounding factor.</p>","PeriodicalId":101400,"journal":{"name":"Acta medica (Hradec Kralove)","volume":"69 1","pages":"26-31"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica (Hradec Kralove)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14712/18059694.2026.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Otologic symptoms are commonly reported by patients with temporomandibular disorders.
Objective: This study aims to investigate the likely outcome or progression of temporomandibular disorders with and without accompanying otologic symptoms when treated in the dental clinic.
Methods: The study is registered under the International Standard Randomised Controlled Trial Number: ISRCTN49976724, DOI: 10.1186/ISRCTN49976724. Forty patients with temporomandibular disorders were included and allocated into two groups: Control group (n=20): isolated temporomandibular disorders symptoms, and Experimental group (n=20): temporomandibular disorders symptoms with otologic symptoms (confirmed by otorhinolaryngological evaluation to exclude primary ear pathology). All participants underwent non-invasive, non-pharmacological treatment. The treatment contained physiotherapy and custom-made occlusal splints. Outcomes (full/partial/no recovery) were assessed at 3 months by a single maxillofacial surgeon, with follow-up every 3 weeks. Statistical analysis included Fisher's exact test and odds ratios.
Results: Fisher's exact test revealed a statistically significant association between group allocation and recovery outcomes (χ2=5.979, p=0.041). The odds ratio was 5.33.
Conclusion: The presence of otological symptoms accompanying temporomandibular disorders might predict a better prognosis after non-invasive, non-pharmacological treatment, perhaps not as a direct predictor per se but as a confounding factor.